Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Open Biology
|
May 17, 2022
Metabolic control of epigenetic rearrangements in B cell pathophysiology
Beatrice Calciolari, Greta Scarpinello, Laura Quotti Tubi, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
Zaira Spinello, Anna Fregnani, Laura Quotti Tubi, et al.
Clinical and Experimental Medicine
|
June 8, 2026
Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas
Juairia Uddin Dekha, Amir Yami, Laura Quotti Tubi, et al.
Current Cancer Drug Targets
|
May 3, 2017
CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death
Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, et al.
Cell Death Discovery
|
May 25, 2019
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma
Marilena Carrino, Laura Quotti Tubi, Anna Fregnani, et al.
Frontiers in Cell and Developmental Biology
|
August 29, 2022
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
Sabrina Manni, Maria Pesavento, Zaira Spinello, et al.
BMC Cancer
|
October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Blood Cancer Journal
|
February 15, 2018
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma
Sara Canovas Nunes, Martina Manzoni, Marco Pizzi, et al.
Journal of Hematology & Oncology
|
November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
Laura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Cancers
|
September 9, 2022
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
Anna Fregnani, Lara Saggin, Ketty Gianesin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Open Biology
|
May 17, 2022
Metabolic control of epigenetic rearrangements in B cell pathophysiology
Beatrice Calciolari, Greta Scarpinello, Laura Quotti Tubi, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
Zaira Spinello, Anna Fregnani, Laura Quotti Tubi, et al.
Clinical and Experimental Medicine
|
June 8, 2026
Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas
Juairia Uddin Dekha, Amir Yami, Laura Quotti Tubi, et al.
Current Cancer Drug Targets
|
May 3, 2017
CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death
Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, et al.
Cell Death Discovery
|
May 25, 2019
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma
Marilena Carrino, Laura Quotti Tubi, Anna Fregnani, et al.
Frontiers in Cell and Developmental Biology
|
August 29, 2022
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
Sabrina Manni, Maria Pesavento, Zaira Spinello, et al.
BMC Cancer
|
October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Blood Cancer Journal
|
February 15, 2018
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma
Sara Canovas Nunes, Martina Manzoni, Marco Pizzi, et al.
Journal of Hematology & Oncology
|
November 29, 2013
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
Laura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, et al.
Cancers
|
September 9, 2022
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
Anna Fregnani, Lara Saggin, Ketty Gianesin, et al.
Page
of 2